TRANSFORMING GROWTH-FACTOR-BETA-1, BETA-2, AND BETA-3, UROKINASE AND PARATHYROID HORMONE-RELATED PEPTIDE EXPRESSION IN 8701-BC BREAST-CANCER CELLS AND CLONES
C. Luparello et al., TRANSFORMING GROWTH-FACTOR-BETA-1, BETA-2, AND BETA-3, UROKINASE AND PARATHYROID HORMONE-RELATED PEPTIDE EXPRESSION IN 8701-BC BREAST-CANCER CELLS AND CLONES, Differentiation, 55(1), 1993, pp. 73-80
8701-BC is a recently characterized cell line isolated from a primary
ductal infiltrating carcinoma of the breast (d.i.c.), showing some ple
omorphism in cell microanatomy at an ultrastructural level. We have ob
tained different sublines of 8701-BC cells by cloning in soft agar at
different concentrations (0.3% and 0.6%), and we have characterized th
e cloned lines by some morphological and growth parameters. 8701-BC ce
lls and clones have been submitted to analysis by reverse transcriptas
e-linked polymerase chain reaction to detect mRNAs of various cytokine
s (transforming growth factor-beta s, tumour necrosis factors, interle
ukin 1s, interleukin 6, parathyroid hormone-related peptide, gamma int
erferon) and of urokinase, which are bioactive molecules commonly invo
lved in cell-cell and cell-stroma interactions at primary and/or secon
dary sites of invasion. The aims of the present investigation were to
determine: (a) if the corresponding genes are active in 8701-BC cell l
ine and (b) if the sublines tested exhibit transcriptional heterogenei
ty. The results obtained show that 8701-BC cells express transcripts o
f transforming growth factor-beta s, urokinase and parathyroid hormone
-related peptide (PTHrP), the latter product being responsible for the
cancer-associated humoral hypercalcemic syndrome. Moreover, while the
first two mRNAs are detectable in all the sublines tested, PTHrP is e
xpressed almost uniquely by the clones isolated in 0.6% agar which exh
ibit a peculiar morphological appearance, a higher growth rate and a m
ore active invasive behaviour in vitro. The correlation between PTHrP
expression and the potentially more aggressive subpopulation(s) of 870
1-BC cell line suggests the possibility to use also PTHrP as a marker
of high risk of malignancy in breast carcinoma.